Investors Heavily Search Veeva Systems Inc. ( VEEV ) : Here is What You Need to Know
Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is Veeva's Vault CRM Emerging as the Standard for Top Biopharma?
VEEV's Vault CRM is gaining traction with top biopharma firms like Merck, Gilead, and BMS, signaling its rise as the industry's commercial standard.
Veeva Systems ( VEEV ) Recently Broke Out Above the 50-Day Moving Average
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
Here's How Much You Would Have Made Owning Veeva Systems Stock In The Last 10 Years - Veeva Systems ( NYSE:VEEV )
Veeva Systems ( NYSE: VEEV ) has outperformed the market over the past 10 years by 15.47% on an annualized basis producing an average annual return of 28.63%. Currently, Veeva Systems has a market capitalization of $47.58 billion.
Here is What to Know Beyond Why Veeva Systems Inc. ( VEEV ) is a Trending Stock
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today - Veeva Systems ( NYSE:VEEV )
Veeva Systems VEEV has outperformed the market over the past 10 years by 13.89% on an annualized basis producing an average annual return of 26.53%. Currently, Veeva Systems has a market capitalization of $45.01 billion.
Gilead Sciences Commits to Veeva Vault CRM - Veeva Systems ( NYSE:VEEV )
Next generation CRM with deep capabilities and agentic AI PLEASANTON, Calif., Sept. 10, 2025 /PRNewswire/ -- Veeva Systems VEEV today announced that Gilead Sciences has committed to Veeva Vault CRM.
This Veeva Systems Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Afya ( NASDAQ:AFYA ) , Sanofi ( NASDAQ:SNY )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. JP Morgan analyst Alexei Gogolev upgraded Veeva Systems Inc.
2 Growth Stocks to Buy and Hold for the Next Decade
These companies check many of the boxes that long-term market leaders typically do.
Is Trending Stock Veeva Systems Inc. ( VEEV ) a Buy Now?
Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Interpreting Veeva ( VEEV ) International Revenue Trends
Explore Veeva's (VEEV) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up
Veeva Systems' second-quarter earnings and revenues beat estimates, margins expand and raised FY26 outlook lifts shares higher.
Veeva Systems Analysts Increase Their Forecasts After Better-Than-Expected Q2 Results - Veeva Systems ( NYSE:VEEV )
Veeva Systems Inc. VEEV reported better-than-expected earnings for the second quarter on Wednesday. The company posted quarterly earnings of $1.99 per share which beat the analyst consensus estimate of $1.90 per share.
Veeva Systems Lifts Outlook on CRM Wins
Veeva Systems ( NYSE:VEEV ) reported fiscal second quarter 2026 results on August 27, 2025, delivering $789 million in revenue and raising full-year billings guidance by $35 million. The quarter featured a strategic resolution withIQVIA ( NYSE: IQV ) , rapid Vault CRM adoption among top-20 ...
Veeva Revenue Jumps 17% in Fiscal Q2
Veeva Systems ( NYSE:VEEV ) , a leading provider of cloud software and data solutions for the life sciences industry, delivered its fiscal second quarter 2026 earnings on Aug. 27, 2025. The standout headline was GAAP revenue of $789.1 million, up 17.0% from the previous year, exceeding the ...
Veeva Systems ( VEEV ) Surpasses Q2 Earnings and Revenue Estimates
Veeva (VEEV) delivered earnings and revenue surprises of +4.74% and +2.80%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
S&P 500 Tests Records Ahead Nvidia Results, MongoDB Rockets - MongoDB ( NASDAQ:MDB )
Wall Street trades cautiously as investors await Nvidia's earnings, with major indices hovering near record highs. Nvidia stock edges up 0.1%; traders eye Blackwell chip growth, China updates and margins as key drivers.
Here's How Much $1000 Invested In Veeva Systems 10 Years Ago Would Be Worth Today - Veeva Systems ( NYSE:VEEV )
Veeva Systems VEEV has outperformed the market over the past 10 years by 15.78% on an annualized basis producing an average annual return of 28.25%. Currently, Veeva Systems has a market capitalization of $46.69 billion.
Seeking Clues to Veeva ( VEEV ) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Evaluate the expected performance of Veeva (VEEV) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Veeva Systems Inc. ( VEEV ) is Attracting Investor Attention: Here is What You Should Know
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Veeva Systems ( VEEV ) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today - Veeva Systems ( NYSE:VEEV )
Veeva Systems VEEV has outperformed the market over the past 10 years by 14.98% on an annualized basis producing an average annual return of 26.94%. Currently, Veeva Systems has a market capitalization of $45.41 billion.
Veeva Systems ( VEEV ) Exceeds Market Returns: Some Facts to Consider
Veeva Systems (VEEV) concluded the recent trading session at $279.18, signifying a +1.36% move from its prior day's close.
2 Top Stocks to Invest $1,000 in Right Now
These stocks continue to beat expectations.
Reasons to Add Veeva Systems Stock to Your Portfolio for Now
VEEV's strong first quarter, product innovations and strategic deals drive growth prospects despite rising costs.
Evolent Health ( EVH ) Reports Q2 Loss, Misses Revenue Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of -211.11% and -2.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems ( VEEV ) Declines More Than Market: Some Information for Investors
Veeva Systems (VEEV) closed at $279.76 in the latest trading session, marking a -1.02% move from the prior day.
Veeva Systems Inc. ( VEEV ) Is a Trending Stock: Facts to Know Before Betting on It
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Schrodinger, Inc. ( SDGR ) Reports Q2 Loss, Beats Revenue Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of +28.92% and +5.08%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Veeva ( VEEV ) Upgraded to Buy: What Does It Mean for the Stock?
Veeva (VEEV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Nuveen ESG Mid-Cap Growth ETF ( NUMG ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Veeva Systems ( VEEV ) Stock Moves -1.09%: What You Should Know
In the closing of the recent trading day, Veeva Systems (VEEV) stood at $281.11, denoting a -1.09% move from the preceding trading day.
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition?
VEEV leans on Vault R&D for growth as AI-native rivals rise, testing its edge in clinical and regulatory innovation.
Here's Why Veeva Systems ( VEEV ) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wall Street Analysts See Veeva ( VEEV ) as a Buy: Should You Invest?
The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
OPRX's subscription shift, DAAP platform, and HCP-DTC reach suggest a moat is forming-but is it built to last?
Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?
Hims & Hers benefits from strong product demand and subscriber growth ahead of second-quarter 2025 earnings, fueled by weight loss and specialty care uptake.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Veeva Systems Inc. ( VEEV ) Hits Fresh High: Is There Still Room to Run?
Veeva (VEEV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down
Edwards Lifesciences posts a second-quarter 2025 earnings and revenue beat, with strong growth in TAVR and TMTT segments despite margin pressure.
Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today - Veeva Systems ( NYSE:VEEV )
Veeva Systems VEEV has outperformed the market over the past 10 years by 15.19% on an annualized basis producing an average annual return of 26.84%. Currently, Veeva Systems has a market capitalization of $47.60 billion.
Veeva Systems ( VEEV ) Beats Stock Market Upswing: What Investors Need to Know
Veeva Systems (VEEV) reached $291.25 at the closing of the latest trading day, reflecting a +1.83% change compared to its last close.
Veeva's Vault Vision: Can It Thrive After Parting With Salesforce?
VEEV stock climbs 36% YTD as it accelerates its shift off Salesforce, betting on Vault to power future growth in life sciences.
Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
LH tops Q2 estimates with double-digit EPS growth, margin gains and a raised 2025 outlook, lifting shares pre-market.
Investors Heavily Search Veeva Systems Inc. ( VEEV ) : Here is What You Need to Know
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Veeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy?
VEEV's split from Salesforce sets the stage for a high-stakes CRM showdown as both firms double down on life sciences innovation.
Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up
BSX beats Q2 estimates, raises full-year outlook as Cardiovascular sales surge and global revenues climb 22.8%.
Thermo Fisher Q2 Earnings & Revenues Beat, Stock Up in Pre-Market
TMO tops Q2 estimates as new product launches and solid segment growth fuel revenue gains despite margin pressure.
Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises
DGX tops Q2 estimates with 15.2% revenue growth and a strong EPS beat, lifting the stock 3.2% in pre-market trading.
Veeva Systems ( VEEV ) Stock Sinks As Market Gains: Here's Why
Veeva Systems (VEEV) reached $276.46 at the closing of the latest trading day, reflecting a -2.13% change compared to its last close.
